These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15713853)

  • 21. Effect of age and diagnosis on survival of older patients beginning chronic dialysis.
    Byrne C; Vernon P; Cohen JJ
    JAMA; 1994 Jan; 271(1):34-6. PubMed ID: 8258884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Renal replacement therapy in the elderly--against].
    Hillebrand GF
    Dtsch Med Wochenschr; 2004 Apr; 129(16):909. PubMed ID: 15083414
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of renal failure in the light of increasingly limited resources.
    Wing AJ
    Contrib Nephrol; 1985; 44():260-74. PubMed ID: 3987290
    [No Abstract]   [Full Text] [Related]  

  • 24. The quality of life and economic implications of daily dialysis.
    Mohr PE; Neumann PJ; Franco SJ; Marainen J; Lockridge R; Ting G
    Policy Anal Brief H Ser; 1999 Oct; 1(2):1-4. PubMed ID: 11763877
    [No Abstract]   [Full Text] [Related]  

  • 25. Life and death in a welfare state: end-stage renal disease in the United Kingdom.
    Halper T
    Milbank Mem Fund Q Health Soc; 1985; 63(1):52-93. PubMed ID: 3923389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cost-effectiveness analysis of treatment for end-stage renal disease].
    Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
    Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can end-stage renal disease be delayed?
    Naper J
    Hosp Technol Ser; 1994 Dec; 13(15):5-7. PubMed ID: 10139506
    [No Abstract]   [Full Text] [Related]  

  • 28. An analysis of socialized renal medicine.
    Greenwood R
    Nephrol News Issues; 2005 Oct; 19(11):56-7. PubMed ID: 16270736
    [No Abstract]   [Full Text] [Related]  

  • 29. Would you deny this patient dialysis?
    Levine DZ
    Am J Kidney Dis; 1998 Jan; 31(1):131-2. PubMed ID: 9428464
    [No Abstract]   [Full Text] [Related]  

  • 30. Transplant and dialysis: the cost/benefit question.
    Blommers TJ; Schanbacher B; Corry RJ
    Iowa Med; 1984 Jan; 74(1):15-7. PubMed ID: 6423564
    [No Abstract]   [Full Text] [Related]  

  • 31. Justice and cost-containment in end-stage renal disease.
    Johnstone BV
    J Contemp Health Law Policy; 1987; 3():65-84. PubMed ID: 10301637
    [No Abstract]   [Full Text] [Related]  

  • 32. Cost functions for dialysis facilities and the quality of dialysis.
    Escarce JJ; Feldman HI
    Health Serv Res; 1999 Feb; 33(6):1563-6. PubMed ID: 10029497
    [No Abstract]   [Full Text] [Related]  

  • 33. The social issues and ethics of end stage renal disease (ESRD) management.
    Khoo OT
    Singapore Med J; 1982 Feb; 23(1):4-11. PubMed ID: 7051330
    [No Abstract]   [Full Text] [Related]  

  • 34. Recombinant erythropoietin. The effect of the marketplace on socialized patient care.
    Besarab A; Erslev AJ
    ASAIO J; 1993; 39(2):85-6. PubMed ID: 8324265
    [No Abstract]   [Full Text] [Related]  

  • 35. Variations in living donor graft rates by dialysis clinic: effect on outcome and cost of chronic renal failure therapy.
    Baltzan MA; Ahmed S; Baltzan RB; Marshall RP; Thoma EL; Nicol MF
    Clin Nephrol; 1997 Jun; 47(6):351-5. PubMed ID: 9202863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predialysis nephrology care and costs in elderly patients initiating dialysis.
    Stroupe KT; Fischer MJ; Kaufman JS; O'Hare AM; Sohn MW; Browning MM; Huo Z; Hynes DM
    Med Care; 2011 Mar; 49(3):248-56. PubMed ID: 21224743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.
    Liu H; Peng Y; Liu F; Xiao H; Chen X; Huang A; Liu Y
    Ren Fail; 2008; 30(7):685-90. PubMed ID: 18704816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost analysis of alternative treatments in end-stage renal disease.
    Karlberg I
    Transplant Proc; 1992 Feb; 24(1):335. PubMed ID: 1539301
    [No Abstract]   [Full Text] [Related]  

  • 39. Cost-effective treatment modalities for reducing morbidity associated with chronic kidney disease.
    Ferguson TW; Tangri N; Rigatto C; Komenda P
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):243-52. PubMed ID: 25661187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Death or dialysis--a personal view.
    Ward E
    Br Med J (Clin Res Ed); 1984 Dec 22-29; 289(6460):1712-3. PubMed ID: 6440616
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.